Do increased tumor infiltrating lymphocytes co-existing with Homologous Recombination Deficiency provide clues to enhance immunotherapy of ovarian cancer?

Do increased tumor infiltrating lymphocytes co-existing with Homologous Recombination Deficiency provide clues to enhance immunotherapy of ovarian cancer? Gynecol Oncol. 2019 May;153(2):213-214 Authors: Ledermann JA PMID: 31027611 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31027611?dopt=Abstract

Source: Gynecologic Oncology - April 29, 2019 Category: Cancer & Oncology Authors: Ledermann JA Tags: Gynecol Oncol Source Type: research

More News: Cancer | Cancer & Oncology | Immunotherapy | Ovarian Cancer | Ovaries